IGF1 and hyperinsulinism: Additionally, insulin resistance and hyperinsulinemia stimulate increased secretion of insulin-like growth factor I (IGF-I), which further promotes hepatic cell proliferation and suppresses apoptosis, thereby augmenting the risk of NALC (57).